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Regulatory Role for Kru¨ppel-Like Zinc-Finger Protein
Gli-Similar 1 (Glis1) in PMA-Treated and Psoriatic
Epidermis
Gen Nakanishi1,2, Yong-Sik Kim1, Takeshi Nakajima1 and Anton M. Jetten1
In this study, we analyze the expression and potential function of the Kru¨ppel-like zinc-finger protein Gli-similar
protein 1 (Glis1) in normal and inflammatory skin and in the differentiation of epidermal keratinocytes. Glis1
mRNA is not expressed in normal human epidermis, but is significantly induced in psoriatic epidermis and in
mouse skin upon treatment with the tumor promoter phorbol-12-myristate-13-acetate (PMA). The expression of
Glis1 is restricted to the suprabasal layers. These observations suggest that Glis1 expression is associated with
hyperplastic, inflammatory epidermis. Consistent with these findings, Glis1 mRNA is not expressed in
undifferentiated or differentiated normal human epidermal keratinocytes (NHEK) in culture, but is dramatically
induced after the addition of PMA or interferon g. A similar induction of Glis1 mRNA by PMA treatment was
observed in the immortalized epidermal keratinocyte cell line NHEK-HPV, whereas PMA did not induce Glis1 in
HaCaT cells or in several squamous cell carcinoma cell lines. To obtain insight into its function, Glis1 and a
C-terminal deletion mutant Glis1DC were expressed in NHEK-HPV cells and changes in epidermal
differentiation and gene expression examined. Microarray analysis revealed that Glis1DC promoted PMA-
induced epidermal differentiation, as indicated by increased expression of many differentiation-specific genes.
This, in association with its induction in psoriasis, suggests that transcriptional factor Glis1 is involved in the
regulation of aberrant differentiation observed in psoriatic epidermis.
Journal of Investigative Dermatology (2006) 126, 49–60. doi:10.1038/sj.jid.5700018
INTRODUCTION
Hedgehog signaling plays a critical role in embryonic
development and various physiological processes in the
adult, and has been implicated in a number of human
diseases (Toftgard, 2000; Villavicencio et al., 2000; Wicking
and McGlinn, 2001; Bale, 2002; Ruiz i Altaba et al., 2002).
Sonic hedgehog (Shh) signaling involves binding of Shh to the
transmembrane receptor patched. This relieves the inhibition
of downstream transcriptional events by the transmembrane
protein smoothened (Smo). The Gli1–3 proteins constitute
a subfamily of Kru¨ppel-like zinc-finger transcription factors
that mediate the regulation of gene expression downstream
of Shh/patched/Smo (Villavicencio et al., 2000; Ruiz i Altaba
et al., 2002).
Recent studies have demonstrated that Shh/patched/Gli
signaling plays an important role in skin biology and skin
carcinogenesis (Dahmane et al., 1997; Gailani and Bale,
1997; Green et al., 1998; St-Jacques et al., 1998; Chiang
et al., 1999; Grachtchouk et al., 2000; Mill et al., 2003; Oro
and Higgins, 2003; Ikram et al., 2004). The Shh signaling
cascade, largely through the activation of Gli2, is a key
regulatory pathway in hair follicle development (St-Jacques
et al., 1998; Chiang et al., 1999; Wang et al., 2000; Ellis
et al., 2003; Mill et al., 2003). Shh signaling also has an
important function in the regulation of cellular proliferation.
Inappropriate activation of Shh/patched/Gli cascade has been
linked to the development of various human cancers,
including basal cell carcinoma (BCC) (Dahmane et al.,
1997; Gailani and Bale, 1997; Matise and Joyner, 1999;
Grachtchouk et al., 2000; Nilsson et al., 2000; Ruiz i Altaba
et al., 2002).
Recently, we identified three novel proteins, referred to as
Gli-similar 1–3 (Glis1–3), that are closely related to Gli
proteins (Lamar et al., 2001; Zhang and Jetten, 2001; Zhang
et al., 2001; Kim et al., 2002, 2003; Nakashima et al., 2002).
Glis1–3 contain five Cys2–His2-type zinc-finger motifs that
exhibit high homology with those of Gli. However, Glis and
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Gli proteins exhibit little sequence homology outside their
zinc-finger domain. Deletion analysis demonstrated that Glis
proteins contain both repressor and activation domains,
suggesting that they may function as positive as well as
negative regulators of gene transcription (Zhang et al., 2001b;
Kim et al., 2002, 2003). During embryonic development,
Glis1–3 are expressed in a spatial and temporal manner,
suggesting roles in the regulation of different steps in
organogenesis (Lamar et al., 2001; Zhang et al., 2001b;
Nakashima et al., 2002; Kim et al., 2003). During embryonic
development, Glis1 (also named GliH1) expression was most
prominent in craniofacial regions, branchial arches, somites,
and kidney, and was also detected in the dermal papilla (Kim
et al., 2002; Nakashima et al., 2002).
In this study, we examine the potential role of Glis1 in the
epidermis. We show that, in contrast to normal epidermis,
Glis1 mRNA is expressed in the epidermis of human psoriatic
and phorbol-12-myristate-13-acetate (PMA)-treated mouse
skin. In addition, Glis1 expression is induced in normal
human epidermal keratinocytes (NHEK) and immortalized
NHEK-HPV cells by two inflammatory mediators IFNg and
PMA, both of which are strong inducers of epidermal
differentiation (Hennings et al., 1987; Saunders and Jetten,
1994). To obtain insight into the role of Glis1 in epidermal
differentiation, the effect of Glis1 on gene expression was
examined by microarray analysis. These findings indicated
that Glis1 promotes the expression of a number of
differentiation-specific genes. Our observations provide
evidence for a regulatory role of Glis1 in the aberrant
differentiation observed in inflammatory skin.
RESULTS
Glis1 is induced in psoriatic epidermis
To study whether Glis1 has a regulatory function in the
epidermis, we examined the expression of Glis1 mRNA in
normal human skin, skin from psoriatic patients, and BCC. As
shown in Figure 1a, in situ hybridization analysis was unable
to detect any Glis1 mRNA in normal human epidermis. In
addition, Glis1 mRNA was undetectable in sections from
BCC (not shown). In contrast, Glis1 was highly induced in the
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Figure 1. Glis1 mRNA is not expressed in normal epidermis but induced in the suprabasal layers of psoriatic skin. Paraffin sections of normal human skin were
hybridized with a Glis1 antisense probe (a) and adjacent sections were stained with H&E (b) or an anti-involucrin antibody (c). Sections of psoriatic skin were
hybridized with an antisense (d, g) or sense (i) probe for Glis1 and adjacent sections were stained with H&E (e, h) or an anti-involucrin antibody (f). (g) and (h) are
higher magnifications of (d) and (e), respectively. Bars indicate 50 mm.
50 Journal of Investigative Dermatology (2006), Volume 126
G Nakanishi et al.
Regulatory Role for Glis 1
epidermis of psoriatic patients. Glis1 mRNA was undetect-
able in the dermal layer of either normal or psoriatic skin.
Psoriatic epidermis is hyperplastic and is characterized by an
infiltration of neutrophilic inflammatory cells (Van de Kerkhof
and Van Erp, 1996; Fujimoto et al., 1997; Peters et al., 2000).
The thickness of the stratum spinosum and expression of a
number of early differentiation markers, including involucrin,
cornifin, and transglutaminase I, are greatly increased (Michel
et al., 1992; Fujimoto et al., 1997; de Rie et al., 2004). In
psoriatic epidermis, Glis1 mRNA was expressed in the
suprabasal layers and was absent in the basal cell layers
(Figure 1g), suggesting that undifferentiated keratinocytes do
not express Glis1 mRNA. Thus, Glis1 mRNA is induced when
cells transit from the basal into the suprabasal layers and begin
to differentiate. The expression of Glis1 was compared with
that of the differentiation marker involucrin, which is expressed
in the upper stratum spinosum and stratum granulosum of
normal epidermis and is highly induced in the suprabasal layers
of psoriatic epidermis (Figure 1f). These observations demon-
strate that the expression of Glis1 mRNA is greatly enhanced in
psoriatic skin but that, unlike involucrin and many other
differentiation markers, its expression appears to be restricted to
hyperplastic, inflammatory skin. The pattern of Glis1 expres-
sion and its association with hyperplastic, inflammatory skin
suggests that Glis1 does not play a role normal differentiation,
but might be implicated in the regulation of aberrant
differentiation observed in psoriatic epidermis.
Induction of Glis1 expression by PMA in mouse skin
As in psoriatic epidermis, PMA-treated mouse skin exhibits
epidermal hyperplasia and neutrophil-dominant, inflamma-
tory cell infiltration (Stanley et al., 1991). As in normal
human skin, in situ hybridization analysis showed that Glis1
was not detectable in normal mouse epidermis (Figure 2b).
However, Glis1 mRNA expression was induced in PMA-
treated mouse skin (Figure 2d). Expression of Glis1 mRNA
was associated largely with the suprabasal layers of the
epidermis. The sense probe did not detect any signal in PMA-
treated skin (Figure 2e). The induction of Glis1 mRNA by
PMA was supported by reverse transcription (RT)-PCR
analysis. RT-PCR using RNA extracted from normal mouse
skin and mouse skin treated for 1–7 days with PMA confirmed
that Glis1 mRNA was not expressed in untreated mouse skin,
but induced in PMA-treated mouse skin (Figure 2f).
PMA and IFNc induce Glis1 mRNA expression in NHEK cells
We next examined the expression of Glis1 mRNA during
differentiation of cultured human epidermal keratinocytes
(NHEK). NHEK cells growing in the exponential phase do not
express or express low levels of differentiation markers. When
cultures reach confluence, cells become committed to terminal
differentiation and expression of various differentiation markers
are induced (Harvat et al., 1997; Jetten and Harvat, 1997).
Glis1 was undetectable in exponential-phase cultures of NHEK
cells as well as in confluent cultures maintained in medium
with high calcium (Figure 3a, lanes 1 and 2). Differentiated
NHEK cells grown at the air–liquid interface also did not
express Glis1 (Figure 4a, lane 3). The tumor promoter PMA and
IFNg are strong inducers of differentiation in NHEK cells
(Hennings et al., 1987; Saunders et al., 1996). As shown in
Figure 3a (lanes 4 and 5), Glis1 mRNA expression was
increased significantly in NHEK cells treated with PMA or IFNg.
The lack of Glis1 expression during normal (confluence-
induced) epidermal differentiation and the induction of Glis1
during the differentiation process initiated by PMA and IFNg,
two proinflammatory agents, appear to mirror the pattern of
Glis1 expression observed in psoriatic human skin and PMA-
treated mouse skin (Reynolds et al., 1998).
We then compared Glis1 expression in two immortalized
epidermal keratinocyte cell lines NHEK-HPV and HaCaT,
and in the squamous cell carcinoma cell lines SCC13 and
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Figure 2. Induction of Glis1 mRNA expression in PMA-treated mouse skin.
Mouse skin was treated with PMA or vehicle (control) once a day during a
7-day period as described in Materials and Methods. (a–e) Paraffin sections of
skin were obtained and subsequently examined by in situ hybridization
analysis with sense or antisense Glis1 probes. (a) H&E staining of a section of
control mouse skin; (b) control skin section hybridized with a Glis1 antisense
probe; (c) H&E staining of a representative section of PMA-treated skin; (d) a
representative section of PMA-treated skin hybridized with a Glis1 antisense
probes; (e) section of PMA-treated skin hybridized with a Glis1 sense probe.
Bar indicates 50 mm. (f) At the times indicated, skin was isolated, RNA
extracted, and the level of Glis1 and b-actin (control) mRNA determined by
RT-PCR as described in Materials and Methods.
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SQCC/Y1. NHEK-HPV are human epidermal keratinocytes
immortalized by HPV-E6 (Saunders and Jetten, 1994; Harvat
and Jetten, 2001) and retain the ability to undergo differ-
entiation upon PMA treatment and at confluence. In the
exponential phase, NHEK-HPV cells did not express Glis1
mRNA; however, Glis1 expression was induced upon PMA
treatment (Figure 3b). In contrast, PMA did not induce Glis1
mRNA expression in HaCaT, SQCC/Y1, and SCC13 cells,
which do not undergo differentiation after PMA treatment.
The induction of Glis1 mRNA by PMA in NHEK-HPV cells
occurred in a time-dependent manner (Figure 3c). An
increase in Glis1 mRNA expression was observed as early
as 16 hours after the addition of PMA. This induction
paralleled that of the increase in the level of cornifin protein,
a marker of epidermal differentiation (Marvin et al., 1992).
The induction of Glis1 mRNA expression by PMA and IFNg in
NHEK and NHEK-HPV cells was confirmed by real-time
quantitative RT-PCR analysis (Figure 3d).
Expression of Glis1 and Glis1DC in NHEK-HPV cells
To study the role of Glis1 in epidermal differentiation, the
effect of Glis1 and Glis1DC on the differentiation of NHEK-
HPV cells was examined. Using pLXIN retroviral vectors,
NHEK-HPV cell lines that stably expressed Flag-Glis1(full-
length) fusion protein (Flag-Glis1) and a mutant Glis1
containing a carboxy-terminal (C-terminal) deletion (Flag-
Glis1DC) were established (Figure 4a). These cell lines are
referred to as NHEK-HPV-Flag-Glis1 and NHEK-HPV-Flag-
Glis1DC, respectively. The cell line NHEK-HPV(empty),
containing the empty vector pLXIN-Flag, was used as control.
In addition, three corresponding HaCaT cell lines were
established using the same retroviruses.
The expression of Flag-Glis1 fusion protein was examined
by Western blot analysis using anti-Flag M2 antibody. In
protein extracts from NHEK-HPV-Flag-Glis1 and HaCaT-
Flag-Glis1 cells, the anti-Flag antibody recognized the Flag-
Glis1 protein with an expected size of 100 kDa. However, the
antibody reacted with several other smaller proteins (Figure
4a, lanes 2 and 4, respectively). These smaller Flag-Glis1
proteins may be generated by proteolytic processing of Glis1
at two different sites at the C-terminus. Protease inhibitors
included during the isolation of cellular protein did not
prevent this cleavage. We believe that Glis1 might be
specifically processed within the cell. Transient expression
of Flag-Glis1 in NHEK-HPV cells showed similar processing
of Glis1 (Figure 4a, lane 6). In extracts from NHEK-HPV-Flag-
Glis1DC and HaCaT-Flag-Glis1DC cells, the antibody recog-
nized only the Flag-Glis1DC fusion protein of the expected
size of 50 kDa, suggesting that it is not further cleaved. The
latter is in agreement with the conclusion that the processing
of full-length Glis1 involves the C-terminal half of Glis1.
The morphology of the NHEK-HPV-Flag-Glis1 cells was
very similar to that of the parental NHEK-HPV or NHEK-
HPV(empty) cells (Figure 4b and c). Cultures consisted of
migratory cells that formed more loose colonies. NHEK-HPV-
Flag-Glis1DC cells formed more compact colonies with fewer
migrating cells (Figure 4d). These cells were also more
adhesive than parental NHEK-HPV cells (not shown). No
differences in cellular morphology were observed between
HaCaT-Flag-Glis1DC, HaCaT-Flag-Glis1, and HaCaT(empty)
cells (not shown).
Subcellular localization of Glis1
The activity of Gli and Ci proteins is greatly dependent on
their nuclear localization and controlled by suppressor-of-
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Figure 3. (a) Induction of Glis1 mRNA expression in NHEK cells in response
to PMA and IFNg. NHEK cells grown under different conditions were
harvested and RNA isolated. Glis1 and b-actin (control) mRNA levels were
determined by RT-PCR as described in Materials and Methods. RNA from the
exponential phase culture of NHEK cells; lane 2: RNA from confluent NHEK
cells grown in the presence of 1.5 mM CaCl2; lane 3: RNA from cells grown at
an air–liquid interface; lane 4: RNA from cells treated for 24 hours with PMA
(20 nM) and 1.5 mM calcium; lane 5: RNA from cells treated for 24 hours with
IFNg (100 U/ml). (b) PMA induces Glis1 mRNA expression in NHEK-HPV but
not in HaCaT and squamous cell carcinoma cell lines SCC13 and SQCC/Y1.
Cells were treated with 20 nM PMA in the presence of 1.5 mM CaCl2. After
24 hours, RNA was isolated and the level of Glis1 and b-actin (control) mRNA
determined by semiquantitative RT-PCR.
(c) Time course of the induction of Glis1 mRNA in NHEK-HPV cells by PMA.
Cells were treated with 20 nM PMA in the presence of 1.5 mM CaCl2. At the
times indicated, cells were harvested and RNA and protein isolated. Glis1 and
b-actin (control) mRNA levels were determined by RT-PCR. Protein samples
were used for Western blot analysis to determine the level of cornifin
expression. (d) Induction of Glis1 mRNA expression by PMA and IFNg in
NHEK and NHEK-HPV cells. Real-time quantitative RT-PCR analysis was
performed as described in Materials and Methods.
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fused, proteolytic processing, protein kinases, and nuclear
export signals (Kogerman et al., 1999; Villavicencio et al.,
2000; Ruiz i Altaba et al., 2002; Dunaeva et al., 2003). We,
therefore, examined the subcellular localization of Glis1 in
stably transfected cells. In more than 90% of NHEK-HPV-
Flag-Glis1 cells, Glis1 protein localized predominantly to the
cytoplasm (Figure 5a). This cytoplasmic staining likely
represents full-length Glis1 and proteolytically cleaved Glis1
based on the results shown in Figure 4. In contrast, in NHEK-
HPV-Flag-Glis1DC cells, Glis1DC was predominantly loca-
lized in the nucleus (Figure 5c). These results suggest that the
C-terminal region of Glis1 contains a domain that retains
Glis1 in the cytoplasm.
Identification of Glis1-regulated genes
To investigate changes in gene expression resulting from the
expression of Glis1 and Glis1DC, we performed microarray
analysis using a human oligo-chip representing approxi-
mately 17,000 human genes. No significant differences in
gene expression were detected between PMA-treated NHEK-
HPV(empty) and PMA-treated NHEK-HPV-Flag-Glis1 cells
(not shown). In contrast, microarray analysis with PMA-
treated NHEK-HPV(empty) and PMA-treated NHEK-HPV-
Flag-Glis1DC cells identified more than 54 genes that were
downregulated and 23 genes that were upregulated in NHEK-
HPV-Flag-Glis1DC cells (Table 1). The expression of insulin-
like growth factor-binding protein 2, which is involved in
growth inhibition and induction of apoptosis, showed the
largest increase in NHEK-HPV-Glis1DC cells. Interestingly,
among the genes that were significantly increased in NHEK-
HPV-Flag-Glis1DC – compared to NHEK-HPV(empty) cells –
were included many well-established markers of epidermal
differentiation, including S100A9, KLK7, small proline-rich
protein (SPRR) (cornifin), involucrin, and transglutaminase 1.
These observations are consistent with the interpretation that
Glis1 enhances epidermal differentiation. Genes downregu-
lated by Glis1 include the notch-1 receptor Jagged 1, the Wnt
receptor Frizzled-10, the TGFb family member inhibin bA
(activin A), and the activin receptor ACVR1.
The differential expression of several genes was validated
by Northern blot analysis. This analysis confirmed the
enhanced expression of the differentiation markers S100A9,
KLK7, and transglutaminase type I and the downregulation of
Jagged-1 and inhibin bA (Figure 6).
Glis1 expression promotes epidermal differentiation
To analyze the action of Glis1 further, we compared the
induction of differentiation in NHEK-HPV(empty), NHEK-
HPV-Flag-Glisı, and NHEK-HPV-Flag-Glis1DC cells upon
treatment with PMA. The expression of several proteins
NHEK-HPV
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Figure 4. (a) Analysis of Glis1 protein in NHEK-HPV and HaCaT cells expressing Flag-Glis1 and Flag-Glis1 D C. NHEK-HPV and HaCaT cells were infected
with retroviruses containing pLXIN(empty), pLXIN-Flag-Glis1, or pLXIN-Flag-Glis1DC and stable cell lines established as described in Materials and Methods.
Protein extracts (30 mg) were examined by Western blot analysis using anti-Flag M2 antibody. Lane 1: NHEK-HPV(empty); lane 2: NHEK-HPV-Flag-Glis1; lane 3:
NHEK-HPV-Flag-Glis1DC; lane 4: HaCaT-Flag-Glis1FL; lane 5: HaCaT-Flag-Glis1DC; lane 6: NHEK-HPV cells transiently transfected with pCMV-3 Flag-Glis1
construct. A schematic view of the two fusion proteins is shown above the Western blot. Comparison of the cell morphology of NHEK-HPV(empty) (b), NHEK-
HPV-Flag-Glis1 (c), and NHEK-HPV-Flag-Glis1DC (d) cells.
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known to be differentially regulated during epidermal diff-
erentiation was examined by Western blot analysis (Figure 7a).
Previous studies reported that the p53-family member p63 is
downregulated during squamous differentiation in vivo and
in vitro (Pellegrini et al., 2001; Koster et al., 2002). The basal
level of p63 protein in undifferentiated NHEK-HPV(empty),
NHEK-HPV-Flag-Glisı, and NHEK-HPV-Flag-Glis1DC cells
was not significantly different in the three cell lines. In
addition, PMA decreased p63 expression in all the three cell
lines in a similar way (Figure 7a). The differentiation markers
involucrin and cornifin are upregulated by PMA in all the
three NHEK-HPV cell lines; however, their level is increased
to a significantly greater extent in NHEK-HPV-Flag-Glis1DC
than in NHEK-HPV(empty) or NHEK-HPV-Flag-Glisı cells.
These findings are in agreement with the results obtained by
microarray analysis (Table 1) and are consistent with the
hypothesis that Glis1 promotes epidermal differentiation.
Treatment of HaCaT(empty), HaCaT-Flag-Glisı, or HaCaT-
Flag-Glis1DC cells with PMA caused a small reduction in
p63, while cornifin expression was very low in all three cell
lines and remained unchanged after PM treatment (Figure
7b), indicating that Glis1 expression has little effect on the
induction of differentiation in these cells.
DISCUSSION
The Shh/Gli signaling pathway has been reported to play an
important role in skin biology and in skin disease (Dahmane
et al., 1997; Gailani and Bale, 1997; Green et al., 1998; St-
Jacques et al., 1998; Chiang et al., 1999; Grachtchouk et al.,
2000; Mill et al., 2003; Oro and Higgins, 2003; Ikram et al.,
2004). Gli1 and Gli2 are frequently highly induced in BCC
and are critical in the development of these tumors (Green
et al., 1998; Grachtchouk et al., 2000; Nilsson et al., 2000).
In this study, we demonstrate that Glis1 mRNA is not
expressed in normal human epidermis, nor in BCC. These
observations suggest that Glis1 does not play a role in the
development of this type of skin cancer. In contrast to normal
skin, Glis1 mRNA was induced in the epidermis of human
psoriatic skin. Psoriasis is one of the most common chronic
inflammatory skin diseases and is characterized by local
infiltration of T lymphocytes, neutrophils, and monocytes,
and epidermal hyperproliferation (Peters et al., 2000; de Rie
et al., 2004). The latter results in a significant increase in the
thickness of the epidermis, the stratum spinosum in parti-
cular, and a greatly enhanced and aberrant expression of
many differentiation-specific genes. In psoriatic epidermis,
Glis1 mRNA is not detectable in the most basal layers, but
only in the suprabasal layers, particularly throughout the
lower stratum spinosum. Comparison of Glis1 mRNA
expression with that of the early differentiation marker
involucrin shows that its induction precedes the appearance
of involucrin protein. PMA-treated skin exhibits several
similarities with psoriatic skin (Stanley et al., 1991; Marks
and Furstenberger, 1993). Treatment of mouse skin with PMA
causes inflammation, enhances the thickness of the epider-
mis, and causes an increase in the expression of many
differentiation markers. As in the epidermis of psoriatic
patients, expression of Glis1 mRNA is induced in PMA-
treated mouse skin, as shown by in situ hybridization and
confirmed by RT-PCR. In PMA-treated mouse skin, Glis1
mRNA was predominantly localized to the suprabasal layers,
as observed for psoriatic epidermis.
The expression pattern of Glis1 in cultured human
epidermal keratinocytes mirrors that seen in normal and
PMA-treated skin. Glis1 mRNA was undetectable in NHEK
cells growing in the exponential phase or in cells grown at an
air–liquid interface. High Ca2þ , which is not a very effective
inducer of differentiation in NHEK, did not induce Glis1
expression. In contrast, treatment with PMA and IFNg, both of
which are proinflammatory mediators and strong inducers of
growth arrest and differentiation in NHEK cells (Hennings
et al., 1987; Saunders et al., 1996), significantly induced
Glis1 mRNA levels. PMA treatment did not induce Glis1
expression in squamous carcinoma cells that have lost the
ability to differentiate.
Epidermal differentiation is a multi-step process that starts
with the transition of epidermal stem cells into transient
amplifying cells, keratinocytes with a diminished lifespan
(Watt, 2001). These cells subsequently undergo terminal
differentiation that is associated with loss of proliferative
potential and the expression of differentiation-specific genes.
The expression of differentiation markers is carefully con-
trolled and induced at specific steps during differentiation.
The pattern of Glis1 expression observed in skin and cultured
NHEK cells indicates that Glis1 is not required for normal
epidermal differentiation. Instead, Glis1 appears to have a
specific regulatory function in aberrant epidermal differentia-
tion observed in psoriatic and PMA-treated epidermis, where
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Figure 5. Subcellular localization of Glis1 and Glis1 D C in NHEK-HPV
cells. Cells were stained by mouse anti-Flag M2 antibody and Alexa 488-
conjugated anti-mouse IgG and subsequently examined by confocal
microscopy (a, c). Right panels are phase contrast images. (a, b) NHEK-HPV-
Flag-Glis1; (c, d) NHEK-HPV-Flag-Glis1DC.
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Table 1. mRNAs identified by microarray analyses that are (A) increased or (B) decreased in NHEK-HPV-Flag-
Glis1DC compared to NHEK-HPV-Flag keratinocytes
(A)
Gene Genbank # Description Fold increase Function Skin disease
IGFBP2 P18065 Insulin-like growth factor-binding protein 2 13.59 Proliferation/apoptosis
KLK6 Q92876 Kallikrein 6 8.66 Serine proteinase
I_929176 P22466 Preprogalanin 6.42 Neuropeptide* Increased in inflamed
skin
KLK10 O43240 Kallikrein 10 6.33 Serine proteinase
S100A9 P06702 S100 calcium-binding protein A9 6.29 Ca2+-activated signaling protein* Increased in psoriasis
KLK7 P49862 Kallikrein 7 5.89 Stratum corneum serine protease* Increased in psoriasis
KLK8 NM_144507.1 Kallikrein 8 5.59 Serine protease* Increased in psoriasis
IVL P07476 Involucrin 5.38 Structural component of stratum
corneum*
Increased in psoriasis
KLK5 Q9Y337 Kallikrein 5 5.43 Stratum corneum serine protease
G1P2 P05161 Interferon-inducible protein 15 4.77 Ubiquitin-like protein
TXNIP BAB18859.1 Vitamin D-3 upregulated protein-1 4.29 Inhibitor of thioredoxin
NMU P48645 Neuromedin U 3.89 Agonist of G-protein-coupled
receptors
TGM1 P22735 Transglutaminase 1 3.78 Crosslinking enzyme* Increased in psoriasis
SLPI P03973 Secretory leukocyte protease inhibitor 3.7 Antileukoproteinase* Increased in psoriasis/
inflammation
CST6 Q15828 Cystatin E (cystatin M) 3.66 Protease inhibitor* Increased in psoriasis
KRT13 P13646 Keratin 13 3.59 Intermediate filament protein
IFI27 P40305 IFNg-inducible protein 27 3.44 Membrane protein* Increased in psoriasis
S100A8 NM_002964.3 S100 calcium-binding protein A8 3.38 Ca2+-activated signaling protein*
AK3L1 Q9UIJ7 Adenylate kinase 3 like 1 3.28 Unknown
NID2 NM_007361.1 Nidogen 2 3.22 Basement membrane protein/cell
adhesion
HSPA1A NM_005345.4 Heat shock 70 kDa protein 1A 3.16 Protein folding* Increased in psoriasis
CLIC3 NM_004669.1 Chloride intracellular channel 3 3.09 Chloride ion transport
HSPA8 P11142 Heat shock 70 kDa protein 8 3.08 Protein folding* Increased in psoriasis
TIMP3 P35625 Tissue inhibitor of MP3 3 Protease inhibitor* Increased in psoriasis
RUVBL1 Q9Y265 ATP-dependent helicase 2.88 Nuclear protein with
ATPase–helicase motifs
CDH22 Q9UJ99 Cadherin-like 2 2.8 Ca2+-dependent cell adhesion
SPRR1B NM_003125.1 Small proline-rich protein 1B (cornifin) 2.63 Structural component of stratum
corneum*
Increased in psoriasis
CXCL14 AAH03513.1 Chemokine C–X–C motif ligand 14 2.62 Chemokine/senescence
KRT6B NM_005555.2 Keratin 6B 2.53 Epidermal differentiation and
wound response*
Increased in psoriasis
FGFR3 NM_000142.2 Fibroblast growth factor receptor 3 2.52 Receptor for FGF
HAIK1 Q9C075 Intermediate filament protein 2.42 Intermediate filament protein
DDX9 NM_001357.2 DEAD box protein 9 2.42 RNA helicase A
EXO1 AAC69879.1 Exonuclease 1 2.4 Nuclease
FABP5 Q01469 Epidermal fatty acid-binding protein 2.36 Transport fatty acids/keratinocyte
differentiation*
Increased in psoriasis
EPN3 NM_017957.1 Epsin 3 2.35 Involved in wound healing
DEFB1 Q09753 Defensin beta 1 2.19 Host defense*
WDR3 Q9UNX4 WD repeat domain 3 2.34 Unknown
Table 1 continued on following page
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MKI67 P46013 Ki-67 antigen 2.17 Nuclear protein/proliferation* Increased in psoriasis
TUBA6 NM_032704.1 Keratinocyte alpha-tubulin 2.14 Tubulin family member
ID3 CAA01342.1 Inhibitor of DNA-binding 3 2.02 Regulation of proliferation
PHB P35232 Prohibitin 2.09 Suppressor of cell proliferation
BIRC5 O15392 Survivin 1.98 Inhibitor of apoptosis/involved in
G2-M transition
CTSC P53634 Cathepsin C 1.98 Cysteine proteinase
CGREF1 Q99674 Cell growth regulator with EF-hand
domain 1
1.97 Negatively regulator of cell
proliferation
KREMEN2 NM_172229.1 Kringle containing transmembrane
protein 2
1.91 Receptor for Dkk1
GBA P04062 Beta-glucocerebrosidase 1.77 Hydrolysis of glucosylceramide* Increased in psoriasis
SULT2B1 AAC78554.1 Sulfotransferase 2B1 1.59 Cholesterol sulfonation* Increased in psoriasis
S100A4 P26447 S100 calcium-binding protein A4 1.53 Ca2+-activated signaling protein
S100A7 P31151 S100 calcium-binding protein A7
(psoriasin)
1.53 Ca2+-activated signaling protein* Increased in psoriasis
ANGPTL4 NM_016109.1 ANGPTL4 1.5 Lipid metabolism
EPPK1 P58107 Epiplakin 1 1.49 Cytolinker
SPRR2C NM_006518.1 Small proline-rich protein (cornifin) 1.49 Structural component of stratum
corneum
PPL O60437 Periplakin 1.42 Component of (hemi)desmosomes
(B)
Gene Genbank # Description Fold decrease Function Skin disease
ACVR1 Q04771 Activin A receptor type 1 2.23 Receptor for activin
DDIT3 NM_004083.2 DNA damage inducible transcript 3 2.27 Transcription factor
ZFP36L1 Q07352 Zinc-finger protein 2.35 Tristetraprolin family member
ALDH1A3 P47895 Aldehyde dehydrogenase 6 2.37 Retinoic acid metabolism
FOXA2 NM_021784.3 Forkhead box A2 2.55 Transcription factor
HIPK2 AAL37371.1 Homeodomain interacting protein kinase 2 2.58 Signaling
FZD10 Q9ULW2 Frizzled-10 2.6 Receptor for Wnt
SERPINE1 P05121 Plasminogen activator inhibitor 1 2.77 Protease
VEGFC P49767 Vascular endothelial growth factor C 2.79 Angiogenesis
NDRG1 Q92597 N-myc downstream regulated gene 1 2.79 Proliferation
PCK2 Q16822 Phosphoenolpyruvate carboxykinase 2 3.06 Gluconeogenesis
HSPA5 P11021 Heat shock 70 kDa protein 5 3.07 Protein folding
JAG1 NM_000214.1 Jagged 1 3.32 Receptor for notch Decreased in psoriasis
CDKN1A P38936 Cyclin-dependent kinase inhibitor 1A (p21) 3.33 Cell cycle control
NR2F1 NM_005654.2 Nuclear receptor COUPTF1 3.35 Transcription factor
TNFRSF6B NM_032957.1 TNF receptor superfamily member 6b 3.38 Receptor for TNF
TRA1 P14625 Tumor rejection antigen 1 3.69 Chaperone/protein folding
NUCB2 P80303 Nucleobindin 2 3.78 Ca2+-binding protein
MMP1 P03956 Matrix metalloproteinase 1 3.97 Protease
LAMB3 Q13751 Laminin beta 3 4.52 Extracellular matrix
HNT Q9P121 Neurotrimin 5.02 Adhesion
PLAB Q99988 Macrophage inhibitory cytokine 1 5.18 Apoptosis/cancer
INHBA P08476 Inhibin beta A (activin A) 11.48 Proliferation/differentiation Increased in psoriasis
Table 1A. continued
Gene Genbank # Description Fold increase Function Skin disease
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it might be involved in the upregulation of the expression of a
number of squamous differentiation-specific markers or
inflammatory genes. Previous studies have provided indica-
tions for additional functions of Glis1 in skin. During
embryonic development, Glis1 mRNA is expressed in dermal
papilla cells (Zhang et al., 2001b; Nakashima et al., 2002).
These cells have been reported to play a critical role in hair
follicle development (St-Jacques et al., 1998; Oro and
Higgins, 2003). However, hair follicle development in mice
deficient in Glis1 appears undisturbed, suggesting that Glis1
is not required for this process (Nakashima et al., 2002). What
is the function of Glis1 in dermal papilla cells has yet to be
established.
To study the potential role of Glis1 in the regulation of
epidermal differentiation, we examined the effects of Glis1
and Glis1DC expression in an immortalized epidermal
keratinocyte cell line NHEK-HPV. Treatment of NHEK-
HPV(empty), NHEK-HPV-Glis1, and NHEK-HPV-Glis1DC
cells with PMA induces differentiation in all three cell lines
and no significant differences were observed in the repression
of p63, an early event in epidermal differentiation (Pellegrini
et al., 2001; Koster et al., 2002). However, the induction of
the differentiation markers involucrin and cornifin was
significantly elevated in NHEK-HPV-Glis1DC cells compared
to NHEK-HPV(empty) and NHEK-HPV-Glis1. These observa-
tions are consistent with the hypothesis that Glis1 does not
act at the level of commitment to differentiation, but
promotes the expression of the differentiated phenotype.
Analysis of the expression of Glis1 protein showed that
Glis1 was proteolytically cleaved, that Glis1 and Glis1DC
have a different subcellular localization. Previous studies
have shown that the regulation of Gli protein activity involves
activation by Shh, proteolytic processing, and translocation to
the nucleus (Kogerman et al., 1999; Ruiz i Altaba, 1999;
Villavicencio et al., 2000; Dunaeva et al., 2003). Mouse Gli2
contains a repressor domain near its amino-terminus that is
cleaved off to generate a transcriptionally active form, and
overexpression of the latter induces tumor formation in
mouse skin (Grachtchouk et al., 2000; Sheng et al., 2002).
Transient transfection of Glis1 or Glis1DC inhibits Gli1-
mediated transcriptional activation, suggesting that both
Glis1 proteins function as repressors (unpublished observa-
tions). The lack of a cellular response in NHEK-HPV-Glis1
cells might be due to the observation that Glis1 is largely
localized to the cytoplasm. Removal of the C-terminus results
in the translocation of Glis1DC to the nucleus and enables it
to induce changes in gene transcription.
To obtain greater insight into the possible role of Glis1 in
the regulation of gene expression during the differentiation of
epidermal keratinocytes, we compared the pattern of gene
expression between PMA-treated NHEK-HPV(empty) and
NHEK-HPV-Glis1DC cells by microarray analysis. This
analysis identified more than 22 genes that were down-
regulated and 54 genes that were upregulated in NHEK-HPV-
Glis1DC compared to NHEK-HPV(empty) cells (Table 1).
Many of these genes encode proteins for which specific
functions in epidermal differentiation have been reported.
The notch-1 receptor Jagged 1 and the TGFb family member
inhibin bA (activin A) belong to the group of genes down-
regulated in NHEK-HPV-Glis1DC cells. Jagged 1 has been
reported to be expressed in the basal layer of the epidermis
and downregulated in psoriatic epidermis (Thelu et al.,
2002). In contrast, inhibin bA, which plays a positive role in
cell proliferation, is increased in psoriasis (Hubner et al.,
1996). Genes expressed at higher levels in NHEK-HPV-
Glis1DC cells include the crosslinked envelope precursors,
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Figure 6. Validation of several differentially expressed genes identified by
microarray analysis. RNA isolated from PMA-treated NHEK-HPV(empty),
NHEK-HPV-Flag-Glis1, and NHEK-HPV-Flag-Glis1DC cells were examined
by Northern blot analysis using radiolabeled cDNA probes for S100A9,
transglutaminase type I (TGM1), kallikrein 7 (KLK7), Jagged-1 (JAG1), and
inhibin bA (INHBA) as described in Materials and Methods.
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Figure 7. (a) Glis1 D C enhances PMA-induced differentiation in NHEK-HPV
cells. NHEK-HPV(empty), NHEK-HPV-Glis1, and NHEK-HPV-Glis1DC cells
were treated with vehicle (control; lanes 1, 4, 7), 2 nM PMA (lanes 2, 5, 8), or
20 nM PMA in the presence of 1.5 mM CaCl2 (lanes 3, 6, 9). After 24 hours
treatment, cells were collected and proteins examined by Western blot
analysis using antibodies for p63, involucrin, and cornifin. (b) Glis1DC does
not induce differentiation in HaCaT cells. Cells were treated for 24 hours with
vehicle or 50 nM PMA and 1.5 mM CaCl2. Proteins were examined by Western
blot analysis for p63 and cornifin expression.
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involucrin and SPRRs (or cornifins), the crosslinking enzyme
transglutaminase I that catalyzes the crosslinking between
these structural proteins, and sulfotransferase Sult2B1b,
which catalyzes the formation of cholesterol sulfate. These
observations are in agreement with the hypothesis that the
expression of Glis1DC promotes differentiation.
It is interesting to note that many of these genes, including
involucrin, transglutaminase 1, several of the kallikrein serine
proteases, the protease inhibitor cystatin E, epidermal fatty
acid-binding protein, beta-glucocerebrosidase, and S100
calcium-activated signaling proteins have been reported to
be significantly induced in psoriatic epidermis (Michel et al.,
1992; Fujimoto et al., 1997; Peters et al., 2000; Kuwae et al.,
2002; Zeeuwen et al., 2002; Eckert et al., 2004) (see * in
Table 1). S100A9 and S100A8 are not or are minimally
expressed in normal epidermis, but are highly expressed in
psoriatic epidermis (Eckert et al., 2004). In addition, many of
these genes are induced in PMA-treated epidermis (Michel
et al., 1992; Owens et al., 1996). The enhanced expression of
several differentiation-specific genes in epidermal keratino-
cytes overexpressing Glis1DC, in combination with the
observations that Glis1 is induced in psoriatic and PMA-
treated epidermis, suggests that there may be a link between
these events. Since Glis1 functions as a transcriptional
regulator (Kim et al., 2002), it is tempting to hypothesize
that the expression of at least a subset of genes induced in
psoriasis might be regulated by Glis1. Glis1 regulates gene
transcription by binding to Glis DNA response elements
(Glis-RE; consensus sequence ACCACCCA) in the promoter
regulatory region of target genes (Kim et al., 2002). Although
Glis1DC appears to act as a repressor, it might enhance the
expression of differentiation-specific genes by inhibiting the
expression of another transcriptional repressor. Further study
is needed to determine whether Glis1 regulates these genes
directly or indirectly.
In summary, in this study, we demonstrate that Glis1 is not
expressed in normal epidermis but is induced in psoriatic and
PMA-treated skin and in PMA- and IFNg-treated epidermal
keratinocytes. Expression of Glis1DC in epidermal keratino-
cytes NHEK-HPV results in enhanced induction of a great
number of differentiation-specific genes after treatment with
PMA. Our observations indicate that expression of Glis1
promotes epidermal differentiation and suggest a regulatory
role for Glis1 in aberrant epidermal differentiation and
remodeling in psoriatic and PMA-treated skin.
MATERIALS AND METHODS
Cell lines and cell culture
NHEK were obtained from Cambrex (Walkersville, MD). NHEK-HPV
cells is an immortalized cell line derived by stable integration of the
plasmid pHPV-18 (Harvat and Jetten, 2001). NHEK, SCC13, SQCC/
Y1 cells, HaCaT cells, and NHEK-HPV cells were grown in KGM
(Gibco BRL, Gaithersburg, MD) as described previously (Saunders
and Jetten, 1994).
Retroviral vectors
The entire coding sequence of mouse Glis1 and a C-terminal
truncated mouse Glis1, in which the region immediately following
the zinc-finger domain (518S) up to the C-terminus was deleted, were
amplified by PCR and subcloned into pCMV3xFlag 7.1 (Sigma, St
Louis, MO), generating pCMV-Flag-Glis1 and pCMV-Flag-Glis1DC,
respectively. Flag-Glis1 and Flag-Glis1DC were re-amplified and
then subcloned into the retroviral vector pLXIN (BD Biosciences
Clontech, Palo Alto, CA). Retroviral infection and neomycin
selection were carried out as described (Stapleton et al., 2005).
The established cell lines are referred to as NHEK-HPV(empty),
NHEK-HPV-Flag-Glis1, NHEK-HPV-Flag-Glis1DC, HaCaT(empty),
HaCaT-Flag-Glis1, and HaCaT-Flag-Glis1DC.
Western blot analysis
Cells were lysed in lysis buffer (60 mM Tris-HCl, pH 6.8, 2% SDS,
10% glycerol, 10 mM DTT, 1 mM phenylmethylsulfonyl fluoride,
aprotinin, and leupeptin). The proteins were analyzed by Western
blot analysis using the ECL Western Blotting Kit (Amersham
Pharmacia Biotech., Piscataway, NJ) as described. Rabbit anti-
cornifin antibody, mouse anti-involucrin antibody (Sigma), and
mouse anti-p63 antibody (Santa Cruz Biotech., Santa Cruz, CA) were
used as described previously (Fujimoto et al., 1997; Daniely et al.,
2004). Peroxidase-conjugated anti-mouse and anti-rabbit IgG were
purchased from Chemicon (Temecula, CA). Antibodies were diluted
in phosphate-buffered saline containing 5% milk and 0.01% Tween
20.
RT-PCR analysis
Total RNA was prepared with TriReagent (Sigma) or RNeasy mini Kit
(Qiagen, Valencia, CA). cDNA was synthesized using the Super-
ScriptIII first-strand cDNA synthesis system for RT-PCR (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. Semi-
quantitative PCR was carried out using the following primer pair for
mouse and human Glis1: forward primer 50-TCAGCAACTCCAGC
GACCGC and reverse primer 50-GGAGCCAGGA-TACACACCTG.
Primers for b-actin were used in controls.
Northern blot analysis
Total RNA (20 mg) was isolated using TriReagent (Sigma, St Louis,
MO) and examined by Northern blot analysis as described
previously (Nakajima et al., 2004) with radiolabeled probes for
transglutaminase I, kallikrein 7, S100A9, Jagged-1, and inhibin bA.
In situ hybridization analysis
Adult mouse skin and human skin were fixed in 4% paraformalde-
hyde, embedded in paraffin, and sections (5 mm thick) prepared for
in situ hybridization analysis as described (Fujimoto et al., 1997). In
situ hybridization analyses with antisense and sense Glis1 probes
were carried out as described previously. Sections were stained with
hematoxylin and eosin (H&E).
Microarray analysis
Microarray analysis was carried out by the NIEHS Microarray Group.
Gene expression analysis was conducted using Agilent human oligo
arrays (Agilent Technologies, Palo Alto, CA), the Agilent Low RNA
Input Fluorescent Linear Amplification Kit protocol, the Agilent In
situ Hybridization Kit protocol, and the Agilent Feature Extraction
software (version 7.1). Images and GEML files were deposited into
Rosetta Resolver (version 3.2, build 3.2.2.0.33) (Rosetta Biosoftware,
Kirkland, WA). The resultant ratio profiles were combined into ratio
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experiments as described (Stoughton and Dai, 2002). Intensity plots
were generated for each ratio experiment and genes were considered
‘‘signature genes’’ if the P-value was less than 0.001. RNA
preparations from two independent experiments were used and
microarray hybridizations were performed in duplicate.
Subcellular localization
Cells overexpressing 3XFlag-Glis1 or 3XFlag-Glis1DC were fixed in
4% paraformaldehyde/phosphate-buffered saline for 15 minutes and
then treated with 0.3% Triton X-100/phosphate-buffered saline for
15 minutes. Cells were subsequently incubated with anti-Flag M2
monoclonal antibody (Sigma) for 1 hour. After washing, cells were
incubated with Alexa Fluor 488-conjugated anti-mouse antibody
(Molecular Probes, OR) for 1 hour. After several washings, Alexa
Fluor 488 fluorescence was examined in a Zeiss confocal micro-
scope LSM 510 (Zeiss, Thornwood, NY) at excitation and emission
frequencies of 488 and 505 nm, respectively.
Immunohistochemical staining
Paraffin-embedded sections of normal and psoriatic skin were stained
immunohistochemically with an anti-involucrin antibody using a
streptavidin–biotin-peroxidase staining kit (Biomedical Technologies
Inc., Stoughton, MA) following the manufacturer’s instructions.
Animal and human skin samples
PMA-treated mouse skin samples were kindly provided by Dr Sung-
Jen Wei (NIEHS, NIH). Animal studies were carried out as reported
previously (Wei et al., 2003). Normal human skin samples were
obtained as excess tissue from unrelated surgical procedures.
Psoriasis samples used were obtained from the pathology archives,
Department of Dermatology, Okayama University Medical School.
Patient consent was obtained and experiments were carried out with
institutional approval and in adherence to the Helsinki guidelines.
Real time quantitative RT-PCR analyses
The real-time quantitative RT-PCR reactions were carried out in
triplicate on a 7300 Real Time PCR system using the TaqMans One-
Step RT-PCR mix and pre-designed Assays-on-Demandt primers/
probe set for human Glis1 (Hs00377690_m1) from Applied
Biosystems. All results were normalized to an internal control, the
18S transcript.
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